BlueMountain Capital Management LLC lifted its holdings in Agilent Technologies, Inc. (NYSE:A) by 66.2% in the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 42,458 shares of the medical research company’s stock after buying an additional 16,904 shares during the quarter. BlueMountain Capital Management LLC’s holdings in Agilent Technologies were worth $2,518,000 at the end of the most recent quarter.

Several other institutional investors have also added to or reduced their stakes in A. Parallel Advisors LLC raised its holdings in shares of Agilent Technologies by 5.3% in the second quarter. Parallel Advisors LLC now owns 2,623 shares of the medical research company’s stock valued at $157,000 after buying an additional 131 shares during the last quarter. Trust Co. of Vermont raised its holdings in shares of Agilent Technologies by 1.8% in the second quarter. Trust Co. of Vermont now owns 2,793 shares of the medical research company’s stock valued at $166,000 after buying an additional 50 shares during the last quarter. Penserra Capital Management LLC raised its holdings in shares of Agilent Technologies by 9.5% in the first quarter. Penserra Capital Management LLC now owns 3,496 shares of the medical research company’s stock valued at $184,000 after buying an additional 304 shares during the last quarter. Fiduciary Trust Co. bought a new position in shares of Agilent Technologies in the second quarter valued at about $186,000. Finally, Genovese Burford & Brothers Wealth & Retirement Plan Management LLC raised its holdings in shares of Agilent Technologies by 17.2% in the second quarter. Genovese Burford & Brothers Wealth & Retirement Plan Management LLC now owns 3,319 shares of the medical research company’s stock valued at $196,000 after buying an additional 486 shares during the last quarter.

In other Agilent Technologies news, insider Mark Doak sold 12,421 shares of the firm’s stock in a transaction that occurred on Friday, August 18th. The stock was sold at an average price of $61.57, for a total value of $764,760.97. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Patrick Kaltenbach sold 5,000 shares of the firm’s stock in a transaction that occurred on Thursday, July 13th. The shares were sold at an average price of $61.26, for a total value of $306,300.00. Following the completion of the sale, the insider now directly owns 45,138 shares of the company’s stock, valued at approximately $2,765,153.88. The disclosure for this sale can be found here. Over the last quarter, insiders sold 155,165 shares of company stock valued at $9,768,409.

Several analysts have weighed in on the company. Bank of America Corporation boosted their price objective on Agilent Technologies from $66.00 to $68.00 and gave the stock an “equal weight” rating in a report on Wednesday, August 16th. Morgan Stanley reissued an “overweight” rating on shares of Agilent Technologies in a report on Wednesday, August 16th. Deutsche Bank AG set a $68.00 price objective on Agilent Technologies and gave the stock a “buy” rating in a report on Wednesday, August 16th. Janney Montgomery Scott boosted their price objective on Agilent Technologies from $65.00 to $70.00 and gave the stock a “buy” rating in a report on Wednesday, August 16th. Finally, J P Morgan Chase & Co reissued an “overweight” rating and set a $70.00 price objective on shares of Agilent Technologies in a report on Wednesday, August 16th. Three analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company. The stock has a consensus rating of “Buy” and a consensus price target of $63.91.

Agilent Technologies, Inc. (NYSE A) opened at 65.96 on Monday. Agilent Technologies, Inc. has a 52-week low of $42.92 and a 52-week high of $66.42. The firm has a market capitalization of $21.23 billion, a price-to-earnings ratio of 34.02 and a beta of 1.30. The stock’s 50 day moving average price is $62.40 and its 200 day moving average price is $58.01.

Agilent Technologies (NYSE:A) last issued its earnings results on Tuesday, August 15th. The medical research company reported $0.59 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.52 by $0.07. The business had revenue of $1.11 billion during the quarter, compared to the consensus estimate of $1.09 billion. Agilent Technologies had a return on equity of 16.95% and a net margin of 14.36%. The firm’s revenue for the quarter was up 6.7% on a year-over-year basis. During the same period in the previous year, the company posted $0.49 earnings per share. On average, equities analysts anticipate that Agilent Technologies, Inc. will post $2.32 earnings per share for the current fiscal year.

TRADEMARK VIOLATION WARNING: This piece of content was posted by Daily Political and is the property of of Daily Political. If you are accessing this piece of content on another publication, it was stolen and republished in violation of US & international copyright & trademark legislation. The correct version of this piece of content can be viewed at https://www.dailypolitical.com/2017/09/18/agilent-technologies-inc-a-shares-bought-by-bluemountain-capital-management-llc.html.

Agilent Technologies Profile

Agilent Technologies, Inc provides application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. The Company serves the life sciences, diagnostics and applied chemical markets. It has three business segments: life sciences and applied markets business, diagnostics and genomics business, and Agilent CrossLab business.

Institutional Ownership by Quarter for Agilent Technologies (NYSE:A)

Receive News & Ratings for Agilent Technologies Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies Inc. and related companies with MarketBeat.com's FREE daily email newsletter.